Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mild to Moderate COVID 19 Disease”

149 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 149 results

Testing effectiveness (Phase 2)UnknownNCT04840459
What this trial is testing

Use of Monoclonal Antibodies for the Treatment of Mild to Moderate COVID-19 in Non-Hospitalized Setting

Who this might be right for
Covid19
Sohail Rao 1,000
Testing effectiveness (Phase 2)Study completedNCT04402060
What this trial is testing

APL-9 in Adults With Mild to Moderate ARDS Due to COVID-19

Who this might be right for
COVIDCovid-19Coronavirus+6 more
Apellis Pharmaceuticals, Inc. 72
Testing effectiveness (Phase 2)Study completedNCT04523181
What this trial is testing

Double-blind Study to Evaluate the Safety and Efficacy of Antroquinonol in Mild-Moderate COVID-19 Hospitalized Patients

Who this might be right for
Covid-19
Golden Biotechnology Corporation 124
Not applicableUnknownNCT05894603
What this trial is testing

Effectiveness and Safety of New Oral Antivirals for COVID-19

Who this might be right for
COVID-19
Universidade do Porto 211
Testing effectiveness (Phase 2)Study completedNCT04551911
What this trial is testing

Safety and Efficacy of Rayaldee for Treating Mild to Moderate COVID-19

Who this might be right for
COVID-19CoronavirusSARS-CoV2 Infection
OPKO Health, Inc. 171
Not applicableAvailableNCT04657406
What this trial is testing

Expanded Access to Zofin for Patients With COVID-19

Who this might be right for
Covid19Corona Virus InfectionSARS (Severe Acute Respiratory Syndrome)+1 more
ZEO ScientifiX, Inc.
Testing effectiveness (Phase 2)Study completedNCT05076253
What this trial is testing

Efficacy of Ivermectin in COVID-19

Who this might be right for
SafetySARS-CoV2 InfectionIvermectin Poisoning+1 more
Bangkok Metropolitan Administration Medical College and Vajira Hospital 72
Testing effectiveness (Phase 2)Study completedNCT04891302
What this trial is testing

The Proof of Concept Phase 2 Study to Evaluate the Safety and Efficacy of Clevudine in Patients With Mild and Moderate COVID-19

Who this might be right for
COVID-19
Bukwang Pharmaceutical 104
Large-scale testing (Phase 3)WithdrawnNCT05157243
What this trial is testing

Trial to Evaluate Nitazoxanide for Treatment of Mild or Moderate COVID-19 in Subjects at High Risk of Severe Illness

Who this might be right for
COVID-19
Romark Laboratories L.C.
Post-approval studies (Phase 4)Ended earlyNCT04656691
What this trial is testing

At-Home Infusion Using Bamlanivimab in Participants With Mild to Moderate COVID-19

Who this might be right for
Covid19
Daniel Griffin 139
Not applicableLooking for participantsNCT04363541
What this trial is testing

Local Thermotherapy for Patients With Mild-to-moderate COVID-19

Who this might be right for
COVID-19Thermotherapy
Instituto Nacional de Perinatologia 274
Large-scale testing (Phase 3)Study completedNCT05249777
What this trial is testing

A Phase III, Randomised, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of TD0069 Capsule for Patients With Mild to Moderate COVID-19

Who this might be right for
COVID-19
Sao Thai Duong Joint Stock Company 573
Testing effectiveness (Phase 2)UnknownNCT05947812
What this trial is testing

A Clinical Evaluation of the Safety and Efficacy of Randomized Placebo Versus the 8-aminoquinoline Tafenoquine for Early Symptom Resolution in Patients With Mild to Moderate COVID 19 Disease and Low Risk of Disease Progression

Who this might be right for
COVID 19 DiseaseMild to Moderate COVID 19 DiseaseSARS-CoV-2+2 more
60P Australia Pty Ltd 148
Not applicableStudy completedNCT04481620
What this trial is testing

Development and Validation of a Prediction Model for the Transition From Mild to Moderate Form of COVID-19, Using Data From Chest CT

Who this might be right for
COVID-19
University Hospital, Bordeaux 1,329
Large-scale testing (Phase 3)Ended earlyNCT05242042
What this trial is testing

JT001 (VV116) for the Early Treatment of COVID-19

Who this might be right for
Mild to Moderate COVID-19
Shanghai JunTop Biosciences Co., LTD 381
Testing effectiveness (Phase 2)Study completedNCT04399356
What this trial is testing

Niclosamide for Mild to Moderate COVID-19

Who this might be right for
COVID-19
Tufts Medical Center 73
Not applicableEnded earlyNCT05059080
What this trial is testing

A Six-Month Follow-Up Study of Participants With Coronavirus Disease 2019 (COVID-19) Previously Enrolled in a RO7496998 (AT-527) Study

Who this might be right for
COVID-19Long COVID
Hoffmann-La Roche 72
Not applicableStudy completedNCT04512027
What this trial is testing

Prolectin-M in COVID-19 Patients Having Mild to Moderate Symptoms Not Requiring Oxygen Support.

Who this might be right for
COVID-19
Composite Interceptive Med Science 10
Testing effectiveness (Phase 2)Ended earlyNCT05124210
What this trial is testing

Pharmacokinetics, Pharmacodynamics, and Safety of Single-dose Sotrovimab in High-risk Pediatric Participants With Mild to Moderate COVID-19

Who this might be right for
COVID-19
GlaxoSmithKline 8
Large-scale testing (Phase 3)Temporarily pausedNCT04252664
What this trial is testing

A Trial of Remdesivir in Adults With Mild and Moderate COVID-19

Who this might be right for
COVID-19SARS-CoV-2
Capital Medical University 308
Next Page